Akebia Therapeutics | AKBA - Assets

Stock Price
1.21
Daily Change
-0.15 -11.03%
Monthly
-12.32%
Yearly
-43.19%
Q1 Forecast
1.49

Akebia Therapeutics reported $364.15M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.33B 105.22M Sep/2025
Agios Pharmaceuticals USD 1.3B 88.48M Dec/2025
Akebia Therapeutics USD 364.15M 18.56M Sep/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
Amgen USD 90.59B 445M Dec/2025
Ardelyx USD 486.17M 19.4M Sep/2025
Astellas Pharma JPY 3.6T 153.62B Dec/2025
AstraZeneca USD 114.07B 382M Dec/2025
Bayer EUR 104.21B 1.03B Sep/2025
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Exelixis USD 2.84B 20.87M Dec/2025
Fresenius Medical Care EUR 30.89B 404.18M Sep/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
Ironwood Pharmaceuticals USD 396.06M 53.12M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Karyopharm Therapeutics USD 96.23M 8.65M Sep/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Lexicon Pharmaceuticals USD 225.58M 72.09M Jun/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 66.4M 1.06M Jun/2025
Moderna USD 12.34B 203M Dec/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Pharma Mar EUR 341.66M 6.59M Sep/2025
Prothena USD 352.63M 46.44M Sep/2025
PTC Therapeutics USD 2.64B 9.54M Sep/2025
Qiagen NV USD 6.3B 257.54M Dec/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025
Vanda Pharmaceuticals USD 488.95M 112.19M Dec/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025